Reported complications described in some GLP-1 drug claims have included: Severe or persistent gastrointestinal symptoms , such as ongoing nausea, vomiting, or abdominal pain Delayed stomach emptying (gastroparesis) , which has been described by some individuals as involving bloating, nausea, vomiting, or difficulty tolerating food Intestinal complications , including reduced bowel activity (ileus), which may involve abdominal discomfort, cramping, or vomiting Gallbladder-related conditions , such as gallstones or gallbladder inflammation Blood-clot-related conditions , including deep vein thrombosis or pulmonary embolism, described in some reports and legal filings Vision-related problems , including reports involving non-arteritic anterior ischemic optic neuropathy (NAION) discussed in connection with semaglutide in certain contexts Not everyone who takes a GLP-1 medication experiences these issues, and the relationship between GLP-1 drugs and reported complications continues to be evaluated in legal proceedings

Retatrutide is exciting, but it is still in trials, and its long-term impact remains unknown
Lancet Neurol 19(7):582590 Onaolapo AY, Ojo FO, Adeleye OO, Falade J, Onaolapo OJ (2023) Diabetes mellitus and energy dysmetabolism in Alzheimers disease: understanding the relationships and potential therapeutic targets
When I asked about this and how Agile can still offer these medications after the FDA ban, an Agile customer service agent told me: We do offer compounded GLP-1s
The unique formula also promotes blood glucose management and may reduce collagen breakdown, tying into both weight loss and beauty-from-within benefits
Combine with resistance training and high-protein diets for optimal muscle preservation